Skip to content

A prospective observational study of cognitive changes associated with chemotherapy for pancreatic cancer

A prospective observational study to clarify the actual state of cancer-related cognitive impairment (CRCI) caused by chemotherapy for pancreatic cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1060250049
Enrollment
20
Registered
2025-08-29
Start date
2025-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Sponsors

Ueno Yusuke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The subjects were newly diagnosed with pancreatic cancer at our hospital and were scheduled to undergo chemotherapy.

Exclusion criteria

Exclusion criteria: Patients who have already been diagnosed with dementia

Design outcomes

Primary

MeasureTime frame
Cognitive

Secondary

MeasureTime frame
anxiety and depression

Contacts

Public ContactYusuke Ueno

Kagawa University Hospital

yusukeueno912@yahoo.co.jp+81-878912167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026